what is a glp-1 antagonist Comparing Ozempic, Wegovy and Other Drugs Dual and Triple Gut Peptide
Description
JAMA 326 , 20212030 (2021)

No matter your dose

The guidelines are expected to be published soon, following a public consultation held in September
Here are the drugs they reviewed: Other conditions now being evaluated for GLP-1 effectiveness include: Parkinsons Disease Alzheimers dementia Alcohol use disorder These drugs are also being evaluated for obsessive-compulsive disorder, opioid use disorder, gambling, and other mental health diagnoses, although these are not mentioned in this review

Research strongly suggests yes

They can schedule unlimited check-ins with their healthcare team to address side effects, adjust dosages, or ask questions all at no extra cost
